Chem Genes India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 30-12-2024
- Paid Up Capital ₹ 2.50 M
as on 30-12-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 50.54%
(FY 2022)
- Profit 1916.41%
(FY 2022)
- Ebitda 77.33%
(FY 2022)
- Net Worth 1.74%
(FY 2022)
- Total Assets 11.42%
(FY 2022)
About Chem Genes India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Srivastava, Sunita Srivastava, Ajay Srivastava, and One other member serve as directors at the Company.
- CIN/LLPIN
U24119UP2002PTC026822
- Company No.
026822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chem Genes India Private Limited offer?
Chem Genes India Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Chlorinated Solvents, Industrial Chemicals & Supplies, Chemical Intermediates, Industrial Chemicals, Chemical Reagents & Catalysts, Potassium Salts, Halogenating Agent.
Who are the key members and board of directors at Chem Genes India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Srivastava  | Director | 22-Jul-2002 | Current |
| Sunita Srivastava | Director | 22-Jul-2002 | Current |
Ajay Srivastava  | Additional Director | 25-Nov-2024 | Current |
| Umesh Maurya | Director | 04-Jun-2019 | Current |
Financial Performance of Chem Genes India.
Chem Genes India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.54% increase. The company also saw a substantial improvement in profitability, with a 1916.41% increase in profit. The company's net worth moved up by a moderate rise of 1.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chem Genes India?
Unlock access to Chem Genes India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Magadh Avadh Chemical Industries Private LimitedActive 32 years 4 monthsSuresh Srivastava is a mutual person
- Milan Shyam Bio Sciences Private LimitedActive 5 years 3 months
Suresh Srivastava, Sunita Srivastava and 1 more are mutual person
- Argosy Overseas Private LimitedActive 35 years 6 months
Suresh Srivastava, Sunita Srivastava and 1 more are mutual person
- Ess Cee Biotech (India) Private LimitedActive 38 years 8 months
Suresh Srivastava and Sunita Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chem Genes India?
Unlock and access historical data on people associated with Chem Genes India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chem Genes India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chem Genes India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
